Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade B 146.64 -6.11% -9.54
BLUE closed down 6.11 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical BLUE trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 22 BB Squeeze Started Range Contraction 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.11%
Mar 20 MACD Bearish Signal Line Cross Bearish -4.52%
Mar 20 Spinning Top Other -4.52%
Mar 20 Down 3 Days in a Row Weakness -4.52%

Older signals for BLUE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology New Jersey Rare Diseases Medical Genetics Celgene Genetic Genealogy Human Diseases Summit
Is BLUE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 199.7
52 Week Low 87.49
Average Volume 552,039
200-Day Moving Average 141.0461
50-Day Moving Average 137.839
20-Day Moving Average 151.2925
10-Day Moving Average 152.382
Average True Range 6.5446
ADX 25.14
+DI 25.2756
-DI 21.3068
Chandelier Exit (Long, 3 ATRs ) 141.1162
Chandelier Exit (Short, 3 ATRs ) 146.7438
Upper Bollinger Band 162.7783
Lower Bollinger Band 139.8067
Percent B (%b) 0.3
BandWidth 15.183568
MACD Line 4.5436
MACD Signal Line 5.231
MACD Histogram -0.6873
Fundamentals Value
Market Cap 6.69 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -20.01
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 162.85
Resistance 3 (R3) 164.48 160.71 160.15
Resistance 2 (R2) 160.71 156.58 159.89 159.25
Resistance 1 (R1) 153.68 154.03 151.79 152.04 158.35
Pivot Point 149.91 149.91 148.96 149.09 149.91
Support 1 (S1) 142.87 145.78 140.99 141.24 134.93
Support 2 (S2) 139.10 143.23 138.28 134.03
Support 3 (S3) 132.07 139.10 133.13
Support 4 (S4) 130.43